Researchers use new tool to counter multiple myeloma drug resistance

Moffitt Cancer Center researchers, and colleagues, are pioneering promising research utilizing a monitoring technology that could provide a better understanding of acquired drug resistance and assist in clinical decision-making for developing individualized patient treatments for multiple myeloma.

Read the whole article on Physorg

More from Physorg